Navigation Links
Cambrex Reports Third Quarter 2013 Financial Results
Date:11/1/2013

period last year.  This increase was primarily due to increased sales and production volumes partially offset by higher production costs. 

Selling, general and administrative ("SG&A") expenses were $11.1 million compared to $11.9 million in the same period last year.  The decrease was mainly due to lower personnel expenses.

Research and development expenses were $2.6 million compared to $2.3 million in the same period last year. 

Operating profit increased to $11.3 million from $4.3 million in the same period last year. The increase in operating profit was primarily the result of higher gross profit and lower selling, general and administrative expenses.  EBITDA was $17.0 million compared to $9.6 million in the same period last year. 

Net interest expense was $0.7 million compared to $0.6 million in the same period last year.  This increase was primarily a result of higher average debt.

Equity in losses of partially-owned affiliates, for the Company's portion of Zenara's loss, was $0.5 million compared to $0.6 million in the same period last year.  These amounts include amortization expense of $0.2 million for the third quarters of 2013 and 2012. 

The provision for income taxes was $3.8 million and resulted in an effective tax rate of 37.7%. 

Income from continuing operations was $6.3 million or $0.20 per share compared to $2.0 million or $0.07 per share in the same period last year. 

Loss from discontinued operations, net of tax, was $2.7 million and represents estimated increases in expected future environmental investigation and remediation costs at two former operating sites.

Capital expenditures and depreciation were $6.2 million and $5.7 million, respectively, compared to $5.3 million for both capital expenditures and depreciation in the same period last year. 

Financial Expectations – Continuing Operations
<
'/>"/>

SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cambrex Reports Fourth Quarter And Full Year 2012 Financial Results
2. Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013
3. Cambrex Reports Third Quarter 2012 Financial Results
4. Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
5. Cambrex Announces Significant New Supply Agreement
6. Cambrex To Present At Jefferies 2012 Global Healthcare Conference
7. Cambrex Reports First Quarter 2012 Results
8. IRIDEX Reports 2013 Third Quarter Results
9. Perrigo Reports Record First Quarter Revenue, Adjusted Earnings And Margins
10. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
11. Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... resignation of Mr. Fuxiang Zhang as the ... Ms. Rebecca Yingnan Zhang has been appointed ... directors, effective immediately. Meanwhile, Ms. Zhang resigned from the ...
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "Arthroscopy ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose ... size the world market for Arthroscopy Devices. ... trends impacting the market for these products. ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... KARLSRUHE, Germany, and CHICAGO, November 1, 2011 ... a comprehensive product offering for endoscopic spinal surgery, ... new Multiuse-Set includes instruments for endoscopic facet joint ... iLESSYS® system for 360° decompression, launched in spring ...
... ALLEGAN, Mich., Nov. 1, 2011 Perrigo Company ... Pharmaceuticals, received final approval for Epinastine HCl ophthalmic ... will commence shipment of the product immediately. ... epinastine that is indicated for the prevention of ...
Cached Medicine Technology:joimax® Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011 2Perrigo Announces Launch of Generic Version of Elestat® 2
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to a ... all generations are equally as likely to worry about what ... 75% Gen X, 77% Boomers, 69% Silent Generation), which may ... they are scared of aging, particularly Millennials (47%), Gen X’ers ... Harris Poll in April, 2015 among more than 2,000 U.S. ...
(Date:5/22/2015)... Virginia (PRWEB) May 22, 2015 ... of Health IT solutions, announced today that Bill ... Healthcare is the developer of BlueEHS,a first of ... BlueEHS offers a customizable Electronic Health Records (EHR) ... lab interfaces, a telemedicine-enabled comprehensive patient portal, and ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Gateway Building ... exterior renovations. The services the company specialize in include ... remodeling, basements, pool houses and much more. , ... by the owner of the company. It includes two ... The design was thought out to be used with ...
(Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
(Date:5/22/2015)... 22, 2015 Ticket Down is a reputable ... Rangers NHL Eastern Conference Finals Tickets . All seating ... otherwise in the ticket listing. , For the first ... the top of the Eastern Conference. One of the original ... of ups and downs over the years, but the excitement ...
Breaking Medicine News(10 mins):Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... , ... ... ... ...
... ... ... ... ...
... ... ... ... ...
... , ... ... ... ...
... ... of the First EcoAdvisor to Achieve EcoDirector Level With Their Business. , ... Midland (PRWEB) February 24, 2010 ... the highest level of achievement, EcoDirector status. Michelle and Kris Harvey reached this level ...
... , ... ... ... ...
Cached Medicine News:Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 2Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 3Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 4Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 5Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 2Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 3Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 4Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 5Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 6Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 2Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 3Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 4Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 5Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 6Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 7Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 8Health News:Stroke Conference Daily News Summary 2Health News:Stroke Conference Daily News Summary 3Health News:Stroke Conference Daily News Summary 4Health News:Stroke Conference Daily News Summary 5Health News:Stroke Conference Daily News Summary 6Health News:OnlyGreen Celebrates First EcoDirector 2Health News:ANF Group's Tour de Broward Raises Money for Joe DiMaggio Children's Hospital 2Health News:ANF Group's Tour de Broward Raises Money for Joe DiMaggio Children's Hospital 3Health News:ANF Group's Tour de Broward Raises Money for Joe DiMaggio Children's Hospital 4
Hardy pituitary spoon, bayonet, malleable....
Cushing pituitary spoons, malleable copper, silver plated....
... on the T.L.I.F. market as the premium banana-shaped ... clinical history and the amazing success of the ... sure to be king of the jungle amongst ... mm in height. The footprint is 28 mm ...
... Implant system. Material that has a modulus ... The result is an implant that meets ... while optimizing the fusion environment through an ... design with 5 and 10 degrees of ...
Medicine Products: